Features
AlgenCRISPR next-generation gene-modulation system
Fine-tuned and precise gene editing capability
AlgenBrain AI platform with deep learning models
Predicts RNA signaling networks from gene expression
Processes billions of real-time dynamic gene expression changes
Industrial-scale single-cell gene modulation
Reverse engineers disease trajectory for causal biology
High-confidence therapeutic target discovery
Human-centric drug discovery endpoints
Partnerships with pharmaceutical companies like AstraZeneca
Built on discoveries from Nobel Laureate Jennifer Doudna's lab
Multimodal target discovery with PandaOmics
De novo small molecule design with Chemistry42
Antibody and protein engineering with Generative Biologics
Clinical trial outcome prediction with inClinico
Generative scientific reasoning with Science42:DORA
Large Language Models of Life (LLLMs) for biological sequences
NLP-based literature mining with Nach01
PreciousGPT for longevity and aging research
Automated hit-to-lead optimization
IND-enabling study support
Multi-target pipeline management
AI-driven biomarker identification
Target-to-hit in as little as 18 months
